As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...

In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers' ...

The healthcare industry is slowly moving away from fee-for-service care models and toward value-based care — but contracting in these arrangements remains especially difficult for behavioral ...

Since being launched in 2022, crisis counselors working for the 988 Suicide & Crisis Lifeline have answered more than 10 million calls. The hotline provides free, confidential support for people ...

Over the past few years, the metabolic health space has been buzzing due to a mix of increasing awareness, novel drugs and personalized health tools. One of the most impactful developments in ...

Burnout among clinicians and staff remains a significant issue in healthcare, with widespread implications for patient care, staff retention, and the financial health of healthcare organizations.

As a pharmacist and Tennessee state senator, I’ve seen firsthand how healthcare quality — or the lack of it — impacts lives. It’s easy to assume that America has one of the best healthcare ...

Investment in digital youth mental health is on the rise. And for good reason: more than 21% of young Americans battle a mental or behavioral health disorder. But as more companies enter the space ...

At the HLTH conference in Las Vegas, MedCity News Editor-in-Chief Arundhati Parmar, Senior Reporter Katie Adams and Reporter Marissa Plescia interviewed executives who offered their insights on ...

What’s wrong with healthcare is often discussed. And indeed, there is no shortage of challenges that the industry faces: healthcare disparities, provider burnout, rising costs, lack of access to ...

Generative artificial intelligence has taken the world by storm. At the snap of a finger, or a few clacks on the keyboard, anyone with internet access can conjure up academic essays, legal ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million ...